Trade

with

Regeneron Pharmaceuticals Inc
(NASDAQ: REGN)
AdChoices
394.82
+10.30
+2.68%
After Hours :
-
-
-

Open

387.00

Previous Close

384.52

Volume (Avg)

370.37k (792.64k)

Day's Range

386.50-397.00

52Wk Range

257.69-397.00

Market Cap.

38.86B

Dividend Rate ( Yield )

-

Beta

0.97

Shares Outstanding

99.09M

P/E Ratio (EPS)

109.89 (3.52)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 2.10B

    • Net Income

    • 424.36M

    • Market Cap.

    • 38.86B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 15.86

    • PEG (Price/Earnings Growth) Ratio

    • 1.57

    • Beta

    • 0.97

    • Forward P/E

    • 32.79

    • Price/Sales

    • 17.18

    • Price/Book Value

    • 16.26

    • Price/Cash flow

    • 51.55

      • EBITDA

      • 801.00M

      • Return on Capital %

      • 13.58

      • Return on Equity %

      • 20.52

      • Return on Assets %

      • 13.58

      • Book Value/Share

      • 23.44

      • Shares Outstanding

      • 99.09M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 389.40

        • Credit Rating

        • -

        • Analysts

        • 9

        • EPS Estimate

        • 7.15

        • Cashflow Estimate

        • 10.12

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 45.50

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -43.40

          • 17.04

          • Net Income

            Q/Q (last year)

          • 6.10

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 54.58

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 92.93

            • 82.75

            • Pre-Tax Margin

            • 32.10

            • 39.38

            • Net Profit Margin

            • 15.86

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 96.90

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -5.60

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -3.20

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.22

              • 0.76

              • Current Ratio

              • 5.46

              • 2.92

              • Quick Ratio

              • 4.87

              • 2.35

              • Interest Coverage

              • 18.75

              • 38.02

              • Leverage Ratio

              • 1.46

              • 2.21

              • Book Value/Share

              • 23.44

              • 4.75

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 98.04

                • 277.78

                • P/E Ratio 5-Year High

                • 105.03

                • 634.30

                • P/E Ratio 5-Year Low

                • 4.27

                • 124.82

                • Price/Sales Ratio

                • 15.50

                • 9.35

                • Price/Book Value

                • 14.66

                • 8.50

                • Price/Cash Flow Ratio

                • 51.55

                • 50.25

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 20.52

                        (6.00)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • 13.58

                        (4.30)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • 17.54

                        (1.70)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • 169.35k

                      • 117.08k

                      • Inventory Turnover

                      • 1.61

                      • 1.48

                      • Asset Turnover

                      • 0.86

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      760.03M
                      Operating Margin
                      36.11
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      51.55
                      Ownership

                      Institutional Ownership

                      96.52%

                      Top 10 Institutions

                      60.97%

                      Mutual Fund Ownership

                      44.58%

                      Float

                      77.42%

                      5% / Insider Ownership

                      1.32%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • VA CollegeAmerica Growth Fund of America

                      •  

                        3,437,300

                      • -0.54

                      • 3.40

                      • Vanguard Health Care Fund

                      •  

                        2,795,500

                      • 60.34

                      • 2.75

                      • Fidelity® Growth Company Fund

                      •  

                        2,556,123

                      • -1.35

                      • 2.53

                      • VA CollegeAmerica New Perspective

                      •  

                        1,747,700

                      • 10.54

                      • 1.73

                      • Artisan Mid Cap Fund

                      •  

                        1,317,841

                      • -12.13

                      • 1.30

                      • Vanguard Total Stock Mkt Idx

                      •  

                        1,214,560

                      • 1.01

                      • 1.20

                      • iShares Nasdaq Biotechnology

                      •  

                        1,180,087

                      • -1.85

                      • 1.23

                      • Fidelity® Select Biotechnology Portfolio

                      •  

                        1,047,685

                      • 36.47

                      • 1.04

                      • JPMorgan Large Cap Growth

                      •  

                        820,900

                      • 5.76

                      • 0.81

                      • PowerShares QQQ

                      •  

                        810,705

                      • -1.08

                      • 0.85

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Sanofi

                      •  

                        22,535,558

                      • +1.49%

                      • 22.30

                      • Capital World Investors

                      •  

                        7,350,059

                      • -3.71%

                      • 7.24

                      • Wellington Management Company, LLP

                      •  

                        5,669,346

                      • +26.60%

                      • 5.58

                      • Fidelity Management and Research Company

                      •  

                        5,255,677

                      • -8.16%

                      • 5.18

                      • Sands Capital Management, LLC

                      •  

                        4,907,362

                      • +22.32%

                      • 4.83

                      • Vanguard Group, Inc.

                      •  

                        3,913,703

                      • -0.03%

                      • 3.85

                      • State Street Corp

                      •  

                        3,229,271

                      • -0.76%

                      • 3.18

                      • Artisan Partners Limited Partnership

                      •  

                        3,192,014

                      • -1.34%

                      • 3.14

                      • Viking Global Investors LP

                      •  

                        2,963,456

                      • +181.75%

                      • 2.92

                      • T. Rowe Price Associates, Inc.

                      •  

                        2,794,301

                      • -31.89%

                      • 2.75

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Speculative Growth

                      Style

                      Large Growth

                      Regeneron Pharmaceuticals Inc was incorporated in January 1988 in the State of New York. The Company is a biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of se...morerious medical conditions. The Company’s preclinical research programs are in the areas of oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders, inflammation and immune diseases, bone and cartilage, pain, cardiovascular diseases, and infectious diseases. Its manufacturing facilities are located in Rensselaer, New York and consist of three buildings totaling approximately 395,000 square feet of research, manufacturing, office, and warehouse space. It currently has approximately 54,000 liters of cell culture capacity at the...morese facilities. It faces competition from pharmaceutical, biotechnology, and chemical companies. Its competitors are Genentech, Novartis, Pfizer Inc., Bayer HealthCare, Onyx Pharmaceuticals, Inc., Eli Lilly and Company, Abbott, sanofi-aventis, Merck & Co., Amgen Inc., Roche, and others. Its present and future business would be subject to regulation under the United States Atomic Energy Act, the Clean Air Act, the Clean Water Act, the Comprehensive Environmental Response, Compensation and Liability Act, the National Environmental Policy Act, the Toxic Substances Control Act, the Resource Conservation and Recovery Act, national restrictions, and other current and potential future local, state, federal, and foreign regulations.lessless

                      Key People

                      Dr. Leonard S. Schleifer,M.D.,PhD

                      CEO/Director/Founder/President

                      Dr. P. Roy Vagelos,M.D.

                      Chairman of the Board/Director

                      Dr. Alfred G Gilman M.D.,PhD

                      Co-Founder/Director

                      Robert E. Landry

                      CFO/Senior VP, Divisional

                      Douglas S. McCorkle,C.P.A.

                      Assistant Treasurer/Chief Accounting Officer/Controller/Vice President

                      • Regeneron Pharmaceuticals Inc

                      • 777 Old Saw Mill River Road

                      • Tarrytown, NY 10591-6707

                      • USA.Map

                      • Phone: +1 914 847-7000

                      • Fax: -

                      • regeneron.com

                      Incorporated

                      1988

                      Employees

                      2,340

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: